These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 20465258)

  • 1. Short-chain fructooligosaccharide regulates hepatic peroxisome proliferator-activated receptor alpha and farnesoid X receptor target gene expression in rats.
    Fukasawa T; Kamei A; Watanabe Y; Koga J; Abe K
    J Agric Food Chem; 2010 Jun; 58(11):7007-12. PubMed ID: 20465258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of Liver Energy Balance by the Nuclear Receptors Farnesoid X Receptor and Peroxisome Proliferator Activated Receptor α.
    Kim KH; Moore DD
    Dig Dis; 2017; 35(3):203-209. PubMed ID: 28249296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FXR activation improves myocardial fatty acid metabolism in a rodent model of obesity-driven cardiotoxicity.
    Mencarelli A; Cipriani S; Renga B; D'Amore C; Palladino G; Distrutti E; Baldelli F; Fiorucci S
    Nutr Metab Cardiovasc Dis; 2013 Feb; 23(2):94-101. PubMed ID: 21924881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of marker genes for lipid-lowering effect of a short-chain fructooligosaccharide by DNA microarray analysis.
    Fukasawa T; Murashima K; Nemoto T; Matsumoto I; Koga J; Kubota H; Kanegae M
    J Diet Suppl; 2009; 6(3):254-62. PubMed ID: 22435477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new perspective on NAFLD: Focusing on the crosstalk between peroxisome proliferator-activated receptor alpha (PPARα) and farnesoid X receptor (FXR).
    Zhou S; You H; Qiu S; Yu D; Bai Y; He J; Cao H; Che Q; Guo J; Su Z
    Biomed Pharmacother; 2022 Oct; 154():113577. PubMed ID: 35988420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of hepatic UDP-glucuronosyltransferase 1A1 and 1A6 correlated with increased expression of the nuclear constitutive androstane receptor and peroxisome proliferator-activated receptor alpha in male rats fed a high-fat and high-sucrose diet.
    Osabe M; Sugatani J; Fukuyama T; Ikushiro S; Ikari A; Miwa M
    Drug Metab Dispos; 2008 Feb; 36(2):294-302. PubMed ID: 17967931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Consumption of soy protein isolate reduces hepatic SREBP-1c and lipogenic gene expression in wild-type mice, but not in FXR-deficient mice.
    Hashidume T; Sasaki T; Inoue J; Sato R
    Biosci Biotechnol Biochem; 2011; 75(9):1702-7. PubMed ID: 21897047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Farnesol, an isoprenoid, improves metabolic abnormalities in mice via both PPARα-dependent and -independent pathways.
    Goto T; Kim YI; Funakoshi K; Teraminami A; Uemura T; Hirai S; Lee JY; Makishima M; Nakata R; Inoue H; Senju H; Matsunaga M; Horio F; Takahashi N; Kawada T
    Am J Physiol Endocrinol Metab; 2011 Nov; 301(5):E1022-32. PubMed ID: 21862726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of peroxisome proliferator-activated receptor-alpha mRNA in rat liver.
    Sterchele PF; Sun H; Peterson RE; Vanden Heuvel JP
    Arch Biochem Biophys; 1996 Feb; 326(2):281-9. PubMed ID: 8611035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concomitant PPARα and FXR Activation as a Putative Mechanism of NASH Improvement after Gastric Bypass Surgery: a GEO Datasets Analysis.
    Mazzini GS; Khoraki J; Dozmorov M; Browning MG; Wijesinghe D; Wolfe L; Gurski RR; Campos GM
    J Gastrointest Surg; 2019 Jan; 23(1):51-57. PubMed ID: 30206765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced peroxisome proliferator-activated receptor-α and bile acid nuclear receptor NR1H4/FXR may affect the hepatic immune microenvironment of biliary atresia.
    Ma Y; Lu L; Tan K; Li Z; Guo T; Wu Y; Wu W; Zheng L; Fan F; Mo J; Gong Z
    Front Immunol; 2022; 13():875593. PubMed ID: 36090996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice.
    Hsu WH; Chen TH; Lee BH; Hsu YW; Pan TM
    Food Chem Toxicol; 2014 Feb; 64():94-103. PubMed ID: 24275089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Importance of PPAR alpha for the effects of growth hormone on hepatic lipid and lipoprotein metabolism.
    Ljungberg A; Lindén D; Améen C; Bergström G; Oscarsson J
    Growth Horm IGF Res; 2007 Apr; 17(2):154-64. PubMed ID: 17307376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nutrient-sensing nuclear receptors PPARα and FXR control liver energy balance.
    Preidis GA; Kim KH; Moore DD
    J Clin Invest; 2017 Apr; 127(4):1193-1201. PubMed ID: 28287408
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Qin D; Liu S; Lu Y; Yan Y; Zhang J; Cao S; Chen M; Chen N; Huang W; Wang L; Chen X; Zhang L
    Theranostics; 2022; 12(14):6130-6142. PubMed ID: 36168631
    [No Abstract]   [Full Text] [Related]  

  • 16. Role of peroxisome proliferator-activated receptor-alpha (PPARalpha) in bezafibrate-induced hepatocarcinogenesis and cholestasis.
    Hays T; Rusyn I; Burns AM; Kennett MJ; Ward JM; Gonzalez FJ; Peters JM
    Carcinogenesis; 2005 Jan; 26(1):219-27. PubMed ID: 15447978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel aspects of PPARalpha-mediated regulation of lipid and xenobiotic metabolism revealed through a nutrigenomic study.
    Martin PG; Guillou H; Lasserre F; Déjean S; Lan A; Pascussi JM; Sancristobal M; Legrand P; Besse P; Pineau T
    Hepatology; 2007 Mar; 45(3):767-77. PubMed ID: 17326203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of energy metabolism by long-chain fatty acids.
    Nakamura MT; Yudell BE; Loor JJ
    Prog Lipid Res; 2014 Jan; 53():124-44. PubMed ID: 24362249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dietary inulin alleviates hepatic steatosis and xenobiotics-induced liver injury in rats fed a high-fat and high-sucrose diet: association with the suppression of hepatic cytochrome P450 and hepatocyte nuclear factor 4alpha expression.
    Sugatani J; Wada T; Osabe M; Yamakawa K; Yoshinari K; Miwa M
    Drug Metab Dispos; 2006 Oct; 34(10):1677-87. PubMed ID: 16815962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peroxisome proliferator-activated receptor and farnesoid X receptor ligands differentially regulate sebaceous differentiation in human sebaceous gland organ cultures in vitro.
    Downie MM; Sanders DA; Maier LM; Stock DM; Kealey T
    Br J Dermatol; 2004 Oct; 151(4):766-75. PubMed ID: 15491415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.